[1]
Rahmi Aslan, “RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy”, Turkish Journal of Gastroenterology, vol. 34, no. 3, pp. 310–310, Mar. 2023.